共 8 条
[1]
Fetal fibronectin in cervical and vaginal secretions defines a patient populations at high risk for preterm delivery. Lockwood CJ,Senyei AE,Dische MR,et al. The New England Journal of Medicine . 1991
[2]
Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial. Peaceman AM,Andrews WW,Thorp JM,et al. American Journal of Obstetrics and Gynecology . 1997
[3]
Impact of the fetal fibronectin assay on admissions for preterm labor. Joffe GM,Jacques D,Bemis-Heys R,et al. American Journal of Obstetrics and Gynecology . 1999
[4]
Cervico vaginal fibronectin improves the prediction of preterm delivery based on sonographic cervical length in patients with preterm uterine contractions and intact membranes. Gomez R,Romero R,Medina L,et al. American Journal of Obstetrics and Gynecology . 2005
[5]
Fetal fibronectin-how useful is it in the prediction of preterm birth. Leitich H,Kaider A. BJOG . 2003
[6]
Prediction and early detection of preterm birth. Iams JD. Obstetrics and Gynecology . 2003
[7]
Intrauterine infection and preterm delivery. Goldenberg RL,Hauth JC,Andrew WW. The New England Journal of Medicine . 2000
[8]
The effect of fetal fibronectin testing on admissions to a tertiary maternal-fetal medicine unit and cost savings. Giles W,Bisits A,Madsen G,et al. American Journal of Obstetrics and Gynecology . 2000